Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas
Clinical trial NCT00955292 · TERMINATED
Trial details
- NCT number
- NCT00955292
- Sponsor
- Cylene Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2008-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.